Helix BioMedix, Inc. HXBM

Company Overview

Helix BioMedix, Inc. (OTC: HXBM) is a biotechnology and life sciences company historically focused on the development of bioactive peptide technologies for use in therapeutic, dermatological, cosmetic, and antimicrobial applications. The company’s research centered on proprietary peptides designed to support wound healing, skin repair, anti-inflammatory activity, and anti-infective functions. Helix BioMedix primarily operated within the biotechnology, specialty pharmaceutical, and personal care sectors, with revenue opportunities tied to licensing agreements, intellectual property commercialization, and product development collaborations.

The company evolved from an early-stage peptide research enterprise into a developer of commercially oriented peptide platforms targeting both medical and consumer markets. Public disclosures and historical filings indicate that Helix BioMedix pursued strategic partnerships with skincare and healthcare companies to monetize its peptide portfolio. However, publicly available information regarding current large-scale commercial operations, active product sales, or sustained operating scale is limited. Data inconclusive based on available public sources regarding the company’s present operational status and long-term commercial activity.